8Thomas M. Polasek,John O. Miners. Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate[J] 2006,European Journal of Clinical Pharmacology(3):203～208
9Srikanth C. Nallani,Bryan Goodwin,Arthur R. Buckley,Donna J. Buckley,Pankaj B. Desai. Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes[J] 2004,Cancer Chemotherapy and Pharmacology(3):219～229
4Pang KS. Liver perfusion studies in drug metabolism and in drug toxicity.In: Mitchell JR ed. Drug Metabolism and Drug Toxicity[M].1st ed.New York:RavenPress;1984:331-52.
5Mischinger HJ, Walsh TR, Liu T et al.An improved technique for isolated perfusion of rat livers and evaluation of perfusates[J].J Surg Res,1992,53(2): 158-65.
6Pang KS, Terrell JA.Retrogradeperfusion to probe the heterogeneous distribution of hepatic drug metabolizing enzymes in rats[J]. J Pharmacol Exp Ther,1981,216(2):339-46.
7Sahin S, Rowland M. Development of an optimal method for the dual perfusion of the isolated rat liver[J].J Pharmacol Toxicol Methods,1998,39(1):35-43.
8Platzer P, Thalhammer T, Hamilton G et al. Metabolism of Camptothecin, a potent topoisomerase inhibitor, in the isolated perfused rat liver[J]. Cancer Chemother Pharmacol,2000,45(1):50-4.
9Platzer P, Thalhammer T,Reznicek G et al. Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver[J]. Int J Oncol,2001,19(6): 1287-93.
10Salamon A, Vielnascher E, Hagenauer B et al. Metabolism of the new ribonucleotide reductase inhibitor amidox in the isolated perfused rat liver[J]. Anticancer Res,2000,20(5B):3521-6.
